That's such crap. No sales pickup coming. More likely Sanofi calculated the low probability of Uplyso approval and possible market penetration even if approved and decided they don't need to wait for a PLX decision.
Continue to lead the lemmings off the cliff with your incessant touting, even when you've already taken profits. How nice of you.
There will be sales of Ulypso. Quite good sales. You forget the price discount Pfizer is promising for ROW. In Israel with Israeli founder mutations in high relative prevalence, this is an Israeli success story for the people by the people. There will be sales. Quite good sales. See ya in March.